Cefozopran
Systematic (IUPAC) name | |
---|---|
(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)- 2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin- 4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 113359-04-9 |
ATC code | J01DE03 (WHO) |
PubChem | CID 9571080 |
ChemSpider | 7845546 |
UNII | 1LG87K28LW |
KEGG | D01052 |
ChEMBL | CHEMBL1276663 |
Chemical data | |
Formula | C19H17N9O5S2 |
Molar mass | 515.52 g/mol |
| |
| |
(what is this?) (verify) |
Cefozopran (INN) is a fourth-generation cephalosporin.
Spectrum of bacterial susceptibility and resistance
Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.[1]
References
- ↑ "Cefozopran Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.